tioconazole has been researched along with Nail Fungus in 19 studies
tioconazole : A racemate comprising equimolar amounts of (R)- and (S)-tioconazole.
1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that comprises 2-(2,4-dichlorophenyl)ethylimidazole carrying an additional (2-chloro-3-thienyl)methoxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of fractional carbon dioxide laser-assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis." | 9.30 | Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. ( Abd El-Aal, EB; Abdo, HM; Eldestawy, MT; Ibrahim, SM, 2019) |
| "Tazarotene is a synthetic retinoid, with immunomodulating properties and anti-inflammatory activity." | 5.56 | Comparative study between the effect of topical tazarotene 0.1 gel alone vs its combination with tioconazole nail paint in treatment of onychomycosis. ( El-Salam, SSA; Mahmoud, MT; Omar, GA; Said, M, 2020) |
| "Onychomycosis is a common chronic-resistant nail disease." | 5.51 | Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. ( Aliweh, HA; El-Tatawy, RA; Hegab, DS; Shams Eldeen, MA; Talaat, RAZ, 2019) |
| "To evaluate the efficacy of fractional carbon dioxide laser-assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis." | 5.30 | Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. ( Abd El-Aal, EB; Abdo, HM; Eldestawy, MT; Ibrahim, SM, 2019) |
| "The difficulties encountered in the treatment of onychomycosis are primarily related to the necessity of prolonged systemic therapy." | 5.27 | The treatment of onychomycosis with a new form of tioconazole. ( De Simone, C; Ruffilli, MP; Tulli, A, 1988) |
| "To assess the daily treatment costs and the average cost-effectiveness of three topical onychomycosis therapies - amorolfine 5% and ciclopirox 8% nail lacquers and tioconazole 28% nail solution - when used as indicated in France, the UK, Germany and Italy." | 3.73 | Treatment costs of three nail lacquers used in onychomycosis. ( Adjadj, L; Jäckel, A; Lambert, J; Marty, JP, 2005) |
| "Analysis of the computer records of 100 general practices from the CompuFile Doctors Independent Network revealed 1492 patients receiving treatment for onychomycosis in the first 6 months of 1994 with terbinafine, tioconazole, amorolfine or griseofulvin." | 3.70 | A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice. ( Cork, MJ; Haycox, A; Humphrey, KM, 1998) |
| "We report on a 75 year old patient with a bronchial asthma treated at least for 15 years with low dose prednisolone." | 3.69 | [Tinea follicularis presenting as trichophytic Majocchi granuloma]. ( Nolting, C; Seebacher, C; Vennewald, I, 1997) |
| "Onychomycosis is an important medical disorder affecting both health and quality of life of patients." | 2.94 | Fractional CO ( Abdo, HM; Ebadah, MA; Ibrahim, SM; Zaki, AM, 2020) |
| "Tazarotene is a synthetic retinoid, with immunomodulating properties and anti-inflammatory activity." | 1.56 | Comparative study between the effect of topical tazarotene 0.1 gel alone vs its combination with tioconazole nail paint in treatment of onychomycosis. ( El-Salam, SSA; Mahmoud, MT; Omar, GA; Said, M, 2020) |
| "Onychomycosis is a disease that affects many adults, whose treatment includes both oral and topical therapies with low cure rates." | 1.56 | Formulation of Tioconazole and ( Böszörményi, A; Das, S; Kőszegi, T; Nagy, S; Pál, S; Salem, A; Széchenyi, A; Vörös-Horváth, B, 2020) |
| "Onychomycosis is a common chronic-resistant nail disease." | 1.51 | Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. ( Aliweh, HA; El-Tatawy, RA; Hegab, DS; Shams Eldeen, MA; Talaat, RAZ, 2019) |
| "The difficulties encountered in the treatment of onychomycosis are primarily related to the necessity of prolonged systemic therapy." | 1.27 | The treatment of onychomycosis with a new form of tioconazole. ( De Simone, C; Ruffilli, MP; Tulli, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Zaki, AM | 1 |
| Abdo, HM | 2 |
| Ebadah, MA | 1 |
| Ibrahim, SM | 2 |
| El-Salam, SSA | 1 |
| Omar, GA | 1 |
| Mahmoud, MT | 1 |
| Said, M | 1 |
| Vörös-Horváth, B | 1 |
| Das, S | 1 |
| Salem, A | 1 |
| Nagy, S | 1 |
| Böszörményi, A | 1 |
| Kőszegi, T | 1 |
| Pál, S | 1 |
| Széchenyi, A | 1 |
| Abd El-Aal, EB | 1 |
| Eldestawy, MT | 1 |
| Ochando-Ibernón, G | 1 |
| Schneller-Pavelescu, L | 1 |
| Vergara de Caso, EF | 1 |
| Silvestre-Salvador, JF | 1 |
| El-Tatawy, RA | 1 |
| Aliweh, HA | 1 |
| Hegab, DS | 1 |
| Talaat, RAZ | 1 |
| Shams Eldeen, MA | 1 |
| Flores, FC | 1 |
| Rosso, RS | 1 |
| Cruz, L | 1 |
| Beck, RC | 1 |
| Silva, CB | 1 |
| Hernando, S | 1 |
| Menéndez, F | 1 |
| Rodríguez, ME | 1 |
| del Palacio, A | 1 |
| Sidou, F | 1 |
| Soto, P | 1 |
| Marty, JP | 1 |
| Lambert, J | 1 |
| Jäckel, A | 1 |
| Adjadj, L | 1 |
| Gibson, G | 1 |
| Buckley, A | 1 |
| Murphy, GM | 1 |
| Ginarte, M | 1 |
| Pereiro, M | 1 |
| Fernández-Redondo, V | 1 |
| Toribio, J | 1 |
| Nolting, C | 1 |
| Vennewald, I | 1 |
| Seebacher, C | 1 |
| Humphrey, KM | 1 |
| Cork, MJ | 1 |
| Haycox, A | 1 |
| Stubb, S | 1 |
| Heikkilä, H | 1 |
| Reitamo, S | 1 |
| Förström, L | 1 |
| Onayemi, O | 1 |
| Aldridge, RD | 1 |
| Shaw, S | 1 |
| Hay, RJ | 2 |
| Clayton, YM | 2 |
| Moore, MK | 1 |
| Tulli, A | 1 |
| Ruffilli, MP | 1 |
| De Simone, C | 1 |
| Mackie, RM | 1 |
3 trials available for tioconazole and Nail Fungus
| Article | Year |
|---|---|
Fractional CO
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Combined Modality Therapy; Fema | 2020 |
Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Female; Humans; Imidazoles; Lasers, Gas; Ma | 2019 |
A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Topics: Adult; Antifungal Agents; Ciclopirox; Female; Humans; Imidazoles; Lacquer; Male; Morpholines; Nails; | 2004 |
16 other studies available for tioconazole and Nail Fungus
| Article | Year |
|---|---|
Comparative study between the effect of topical tazarotene 0.1 gel alone vs its combination with tioconazole nail paint in treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Humans; Imidazoles; Nicotinic Acids; Onychomycosis; Pain | 2020 |
Formulation of Tioconazole and
Topics: Administration, Topical; Antifungal Agents; Chemical Phenomena; Chromatography, Gas; Drug Compoundin | 2020 |
Allergic contact dermatitis caused by undecylenic acid in an antifungal nail solution.
Topics: Antifungal Agents; Dermatitis, Allergic Contact; Diagnostic Errors; Excipients; Female; Foot Dermato | 2019 |
Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis.
Topics: Administration, Topical; Adult; Antifungal Agents; Combined Modality Therapy; Female; Humans; Imidaz | 2019 |
An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.
Topics: Adhesiveness; Animals; Antifungal Agents; Candida albicans; Chickens; Chorioallantoic Membrane; Drug | 2017 |
[A case of dystrophic fingernail].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Drug Administration Schedule; Hand Dermatoses; | 2004 |
Treatment costs of three nail lacquers used in onychomycosis.
Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; | 2005 |
Allergic contact dermatitis from tioconazole without cross-sensitivity to other imidazoles.
Topics: Adult; Antifungal Agents; Drug Eruptions; Foot Dermatoses; Humans; Imidazoles; Male; Onychomycosis; | 1994 |
Plantar infection by Scopulariopsis brevicaulis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Dermatomycoses; Drug Resi | 1996 |
[Tinea follicularis presenting as trichophytic Majocchi granuloma].
Topics: Aged; Antifungal Agents; Asthma; Granuloma; Humans; Imidazoles; Male; Naphthalenes; Onychomycosis; P | 1997 |
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice.
Topics: Antifungal Agents; Cost-Benefit Analysis; England; Family Practice; Griseofulvin; Humans; Imidazoles | 1998 |
Contact allergy to tioconazole.
Topics: Administration, Cutaneous; Adult; Aged; Antifungal Agents; Dermatitis, Contact; Female; Hand Dermato | 1992 |
Allergic contact dermatitis from tioconazole. A report of 2 cases.
Topics: Adult; Antifungal Agents; Chronic Disease; Dermatitis, Contact; Drug Eruptions; Female; Humans; Imid | 1992 |
A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Drug Therapy, Combination; | 1987 |
The treatment of onychomycosis with a new form of tioconazole.
Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Onychomycosis | 1988 |
Tioconazole nail solution--an open study of its efficacy in onychomycosis.
Topics: Administration, Topical; Female; Humans; Imidazoles; Male; Onychomycosis | 1985 |